Mehmet Toner

Mehmet Toner

Auto-generated profile, based on publicly available information

Mehmet Toner

Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2007 in Nature
Verified
Journal Article
Open access
PDF file
SNSunitha Nagrath
Sunitha Nagrath
LSLecia V. Sequist
Lecia V. Sequist
SMShyamala Maheswaran
Shyamala Maheswaran
DBDaphne W. Bell
Daphne W. Bell
DIDaniel Irimia
Daniel Irimia
MTMehmet Toner
Mehmet Toner
Viable tumour-derived epithelial cells — or circulating tumour cells (CTCs) — are found in peripheral blood from cancer patients, and are the probable origin of intractable metastatic disease. The isolation of such cells from cancer patients has been proven to be very difficult, primarily due to their exceedingly low numbers in peripheral blood. Now a microfluidic platform 'CTC-chip' has been developed, capable of selective, efficient separation of CTCs from the blood of cancer patients. This new tool could be used in the detection and diagnosis of cancers, and to monitor an individual patient's response to therapy. A microfluidic platform that is capable of efficiently and selectively separating viable circulating tumour cells (CTCs) from peripheral blood samples has been developed. Low levels of CTCs in the peripheral blood of patients with various cancers were identified, and it was shown that this device could be used to monitor an individual patient's response to anti-cancer therapy. Viable tumour-derived epithelial cells (circulating tumour cells or CTCs) have been identified in peripheral blood from cancer patients and are probably the origin of intractable metastatic disease1,2,3,4. Although extremely rare, CTCs represent a potential alternative to invasive biopsies as a source of tumour tissue for the detection, characterization and monitoring of non-haematologic cancers5,6,7,8. The ability to identify, isolate, propagate and molecularly characterize CTC subpopulations could further the discovery of cancer stem cell biomarkers and expand the understanding of the biology of metastasis. Current strategies for isolating CTCs are limited to complex analytic approaches that generate very low yield and purity9. Here we describe the development of a unique microfluidic platform (the ‘CTC-chip’) capable of efficient and selective separation of viable CTCs from peripheral whole blood samples, mediated by the interaction of target CTCs with antibody (EpCAM)-coated microposts under precisely controlled laminar flow conditions, and without requisite pre-labelling or processing of samples. The CTC-chip successfully identified CTCs in the peripheral blood of patients with metastatic lung, prostate, pancreatic, breast and colon cancer in 115 of 116 (99%) samples, with a range of 5–1,281 CTCs per ml and approximately 50% purity. In addition, CTCs were isolated in 7/7 patients with early-stage prostate cancer. Given the high sensitivity and specificity of the CTC-chip, we tested its potential utility in monitoring response to anti-cancer therapy. In a small cohort of patients with metastatic cancer undergoing systemic treatment, temporal changes in CTC numbers correlated reasonably well with the clinical course of disease as measured by standard radiographic methods. Thus, the CTC-chip provides a new and effective tool for accurate identification and measurement of CTCs in patients with cancer. It has broad implications in advancing both cancer biology research and clinical cancer management, including the detection, diagnosis and monitoring of cancer10.

27 November 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DCDino Di Carlo
Dino Di Carlo
DIDaniel Irimia
Daniel Irimia
RTRonald G. Tompkins
Ronald G. Tompkins
MTMehmet Toner
Mehmet Toner
Under laminar flow conditions, when no external forces are applied, particles are generally thought to follow fluid streamlines. Contrary to this perspective, we observe that flowing particles migrate across streamlines in a continuous, predictable, and accurate manner in microchannels experiencing laminar flows. The migration is attributed to lift forces on particles that are observed when inertial aspects of the flow become significant. We identified symmetric and asymmetric channel geometries that provide additional inertial forces that bias particular equilibrium positions to create continuous streams of ordered particles precisely positioned in three spatial dimensions. We were able to order particles laterally, within the transverse plane of the channel, with >80-nm accuracy, and longitudinally, in regular chains along the direction of flow. A fourth dimension of rotational alignment was observed for discoidal red blood cells. Unexpectedly, ordering appears to be independent of particle buoyant direction, suggesting only minor centrifugal contributions. Theoretical analysis indicates the physical principles are operational over a range of channel and particle length scales. The ability to differentially order particles of different sizes, continuously, at high rates, and without external forces in microchannels is expected to have a broad range of applications in continuous bioparticle separation, high-throughput cytometry, and large-scale filtration systems.

3 April 2013 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
EOEmre Ozkumur
Emre Ozkumur
ASAjay M. Shah
Ajay M. Shah
JCJordan C. Ciciliano
Jordan C. Ciciliano
BEBenjamin L. Emmink
Benjamin L. Emmink
DMDavid T. Miyamoto
David T. Miyamoto
MTMehmet Toner
Mehmet Toner
A multistage microfluidic chip is capable of sorting rare EpCAM + and EpCAM − CTCs from cancer patients’ whole blood.

27 February 2014 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
NKNezihi Murat Karabacak
Nezihi Murat Karabacak
PSPhilipp S Spuhler
Philipp S Spuhler
FFFabio Fachin
Fabio Fachin
ELEugene J Lim
Eugene J Lim
VPVincent Pai
Vincent Pai
MTMehmet Toner
Mehmet Toner

18 May 2015 in Nature Methods
Verified
Journal Article
Open access
PDF file
ASA Fatih Sarioglu
A Fatih Sarioglu
NANicola Aceto
Nicola Aceto
NKNikola Kojic
Nikola Kojic
MDMaria C Donaldson
Maria C Donaldson
MZMahnaz Zeinali
Mahnaz Zeinali
MTMehmet Toner
Mehmet Toner
The Cluster-Chip provides highly efficient and gentle capture of circulating tumor cell clusters from milliliters of unprocessed whole blood, making it possible to study how these clusters contribute to metastasis. Cancer cells metastasize through the bloodstream either as single migratory circulating tumor cells (CTCs) or as multicellular groupings (CTC clusters). Existing technologies for CTC enrichment are designed to isolate single CTCs, and although CTC clusters are detectable in some cases, their true prevalence and significance remain to be determined. Here we developed a microchip technology (the Cluster-Chip) to capture CTC clusters independently of tumor-specific markers from unprocessed blood. CTC clusters are isolated through specialized bifurcating traps under low–shear stress conditions that preserve their integrity, and even two-cell clusters are captured efficiently. Using the Cluster-Chip, we identified CTC clusters in 30–40% of patients with metastatic breast or prostate cancer or with melanoma. RNA sequencing of CTC clusters confirmed their tumor origin and identified tissue-derived macrophages within the clusters. Efficient capture of CTC clusters will enable the detailed characterization of their biological properties and role in metastasis.

15 August 2005 in Annual Review of Biomedical Engineering
Verified
Journal Article
Closed access
MTMehmet Toner
Mehmet Toner
DIDaniel Irimia
Daniel Irimia
▪ Abstract Accurate, fast, and affordable analysis of the cellular component of blood is of prime interest for medicine and research. Yet, most often sample preparation procedures for blood analysis involve handling steps prone to introducing artifacts, whereas analysis methods commonly require skilled technicians and well-equipped, expensive laboratories. Developing more gentle protocols and affordable instruments for specific blood analysis tasks is becoming possible through the recent progress in the area of microfluidics and lab-on-a-chip-type devices. Precise control over the cell microenvironment during separation procedures and the ability to scale down the analysis to very small volumes of blood are among the most attractive capabilities of the new approaches. Here we review some of the emerging principles for manipulating blood cells at microscale and promising high-throughput approaches to blood cell separation using microdevices. Examples of specific single-purpose devices are described together with integration strategies for blood cell separation and analysis modules.